LFG
CAI

Larson Financial Group’s Caris Life Sciences CAI Stock Holding History

Larson Financial Group’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Buy
1,189
+1,037
+682% +$18.6K ﹤0.01% 1979
2026
Q1 		$2.72K Buy
+152
New +$3.32K ﹤0.01% 2866

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Larson Financial Group's CAI Position: Q2 2026 in Review

Larson Financial Group increased its Caris Life Sciences (CAI) stake by 682% in Q2 2026, buying an estimated $18.6K and bringing the position to 1,189 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

Larson Financial Group first reported a position in CAI in Q1 2026 and has held it in 2 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Larson Financial Group held 1,189 shares of Caris Life Sciences worth $21.2K as of Q2 2026.
  • Larson Financial Group bought 1,037 Caris Life Sciences shares in Q2 2026, an estimated $18.6K.
  • Caris Life Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1979 holding.
  • Larson Financial Group first reported a position in Caris Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.